Prokarium's CEO explains how the company is harnessing bacteria as a therapy, and in the future as a deliverer of therapies

Kristen Albright describes Prokarium's bladder cancer program, which went into the clinic earlier this year, and a platform (including a partnership with Ginkgo) that is designed to use bacteria to deliver therapeutic payloads.